Bacterial meningitis in Africa
暂无分享,去创建一个
F. Iovino | T. Barichello | U. Rohlwink | R. Hasbún | R. Solomons | R. van Toorn | M. van der Kuip | Dan Zaharie | M. Tutu van Furth | Vivian S Namale | Carlos Henrique Rocha Catalão | Marceline Tutu van Furth
[1] T. Lamagni,et al. Incidence and aetiology of infant Gram-negative bacteraemia and meningitis: systematic review and meta-analysis , 2022, Archives of Disease in Childhood.
[2] F. Petronilho,et al. Dysfunctional Glymphatic System with Disrupted Aquaporin 4 Expression Pattern on Astrocytes Causes Bacterial Product Accumulation in the CSF during Pneumococcal Meningitis , 2022, bioRxiv.
[3] Jun Zhang,et al. Homologous Escherichia coli Identified in Cerebrospinal Fluid and Bloodstream , 2021, Frontiers in Cellular and Infection Microbiology.
[4] R. Solomons,et al. The use of thalidomide to treat children with tuberculosis meningitis: A review. , 2021, Tuberculosis.
[5] Lee E. Korshoj,et al. The Prospect of Nanoparticle Systems for Modulating Immune Cell Polarization During Central Nervous System Infection , 2021, Frontiers in Immunology.
[6] Moo-Seung Lee,et al. Escherichia coli Shiga Toxins and Gut Microbiota Interactions , 2021, Toxins.
[7] L. Dodd,et al. Study protocol for a phase 2A trial of the safety and tolerability of increased dose rifampicin and adjunctive linezolid, with or without aspirin, for HIV-associated tuberculous meningitis [LASER-TBM] , 2021, Wellcome open research.
[8] Varinder Singh,et al. Defeating Paediatric Tuberculous Meningitis: Applying the WHO “Defeating Meningitis by 2030: Global Roadmap” , 2021, Microorganisms.
[9] D. Kathayat,et al. Avian Pathogenic Escherichia coli (APEC): An Overview of Virulence and Pathogenesis Factors, Zoonotic Potential, and Control Strategies , 2021, Pathogens.
[10] J. Widengren,et al. Neuronal death in pneumococcal meningitis is triggered by pneumolysin and RrgA interactions with β-actin , 2021, PLoS pathogens.
[11] T. Iype,et al. Neurotuberculosis: an update , 2021, Acta Neurologica Belgica.
[12] C. Whitney,et al. Impact and effectiveness of 13-valent pneumococcal conjugate vaccine on population incidence of vaccine and non-vaccine serotype invasive pneumococcal disease in Blantyre, Malawi, 2006–18: prospective observational time-series and case-control studies , 2020, The Lancet. Global health.
[13] R. Hasbún,et al. Management of Acute Bacterial Meningitis in Children , 2020, Infection and drug resistance.
[14] Xiang-Qi Tang,et al. Detection of Listeria monocytogenes in a patient with meningoencephalitis using next-generation sequencing: a case report , 2020, BMC Infectious Diseases.
[15] E. Tucker,et al. International Survey Reveals Opportunities to Improve Tuberculous Meningitis Management and the Need for Standardized Guidelines , 2020, Open forum infectious diseases.
[16] E. Denamur,et al. The population genetics of pathogenic Escherichia coli , 2020, Nature Reviews Microbiology.
[17] M. Gil,et al. Actin Assembly around the Shigella-Containing Vacuole Promotes Successful Infection , 2020, Cell reports.
[18] S. Normark,et al. The impact of the ancillary pilus‐1 protein RrgA of Streptococcus pneumoniae on colonization and disease , 2020, Molecular microbiology.
[19] D. Briles,et al. New Strategy Is Needed to Prevent Pneumococcal Meningitis , 2020, The Pediatric infectious disease journal.
[20] B. Schmand,et al. Long-term neurological and cognitive outcome, and quality of life in adults after pneumococcal meningitis. , 2020, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[21] R. Geskus,et al. Xpert MTB/RIF Ultra versus Xpert MTB/RIF for the diagnosis of tuberculous meningitis: a prospective, randomised, diagnostic accuracy study , 2020, The Lancet. Infectious diseases.
[22] D. Boulware,et al. Xpert MTB/RIF Ultra for the diagnosis of HIV-associated tuberculous meningitis: a prospective validation study , 2020, The Lancet. Infectious diseases.
[23] R. Zhou,et al. DAMP-sensing receptors in sterile inflammation and inflammatory diseases , 2019, Nature Reviews Immunology.
[24] J. Lewnard,et al. Dose-specific effectiveness of 7- and 13-valent pneumococcal conjugate vaccines against vaccine-serotype Streptococcus pneumoniae colonization in children. , 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[25] Ryan T Novak,et al. Bacterial Meningitis Epidemiology in Five Countries in the Meningitis Belt of Sub-Saharan Africa, 2015-2017. , 2019, The Journal of infectious diseases.
[26] R. Wilkinson,et al. Key considerations in the pharmacotherapy of tuberculous meningitis , 2019, Expert opinion on pharmacotherapy.
[27] Juno Thomas,et al. Outbreak of Listeria monocytogenes in South Africa, 2017–2018: Laboratory Activities and Experiences Associated with Whole-Genome Sequencing Analysis of Isolates , 2019, Foodborne pathogens and disease.
[28] G. Hummer,et al. Membrane perforation by the pore-forming toxin pneumolysin , 2019, Proceedings of the National Academy of Sciences.
[29] Jian-qing He,et al. Treatment outcomes of tuberculous meningitis in adults: a systematic review and meta-analysis , 2019, BMC Pulmonary Medicine.
[30] D. Boulware,et al. Inadequate diagnostics: the case to move beyond the bacilli for detection of meningitis due to Mycobacterium tuberculosis. , 2019, Journal of medical microbiology.
[31] K. Stanley,et al. Application of Cerebrospinal Fluid Host Protein Biosignatures in the Diagnosis of Tuberculous Meningitis in Children from a High Burden Setting , 2019, Mediators of inflammation.
[32] B. Henriques-Normark,et al. The Role of Microglia in Bacterial Meningitis: Inflammatory Response, Experimental Models and New Neuroprotective Therapeutic Strategies , 2019, Front. Microbiol..
[33] H. Welch,et al. Epidemiology of bacterial meningitis in children admitted to Gondar University Hospital in the post pneumococcal vaccine era , 2018, The Pan African medical journal.
[34] J. Forrester,et al. CNS infection and immune privilege , 2018, Nature Reviews Neuroscience.
[35] A. Walker,et al. Trends over time in Escherichia coli bloodstream infections, urinary tract infections, and antibiotic susceptibilities in Oxfordshire, UK, 1998-2016: a study of electronic health records. , 2018, The Lancet. Infectious diseases.
[36] H. Lopardo,et al. Susceptibility to β-lactams in β-hemolytic streptococci. , 2018, Revista Argentina de microbiologia.
[37] M. Anand,et al. Community-acquired Escherichia coli meningitis with ventriculitis in an adult—a rare case report , 2018, Journal of Intensive Care.
[38] B. Henriques-Normark,et al. Receptor Blockade: A Novel Approach to Protect the Brain From Pneumococcal Invasion , 2018, The Journal of infectious diseases.
[39] A. van der Ende,et al. Community-acquired meningitis in adults caused by Escherichia coli in Denmark and The Netherlands. , 2018, The Journal of infection.
[40] R. Geskus,et al. Adjunctive dexamethasone for the treatment of HIV-infected adults with tuberculous meningitis (ACT HIV): Study protocol for a randomised controlled trial , 2018, Wellcome open research.
[41] R. Geskus,et al. A randomised double blind placebo controlled phase 2 trial of adjunctive aspirin for tuberculous meningitis in HIV-uninfected adults , 2018, eLife.
[42] M. Brouwer,et al. Epidemiology of community-acquired bacterial meningitis , 2018, Current opinion in infectious diseases.
[43] P. Cossart,et al. Listeria monocytogenes: towards a complete picture of its physiology and pathogenesis , 2017, Nature Reviews Microbiology.
[44] R. Geskus,et al. Adjunctive dexamethasone for the treatment of HIV-infected adults with tuberculous meningitis (ACT HIV): Study protocol for a randomised controlled trial. , 2018, Wellcome open research.
[45] Mohammad Hossein Khosravi,et al. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016 , 2017, Lancet.
[46] J. A. Woenig,et al. The Role of Neurogenic Inflammation in Blood-Brain Barrier Disruption and Development of Cerebral Oedema Following Acute Central Nervous System (CNS) Injury , 2017, International journal of molecular sciences.
[47] A. van der Ende,et al. Listeria monocytogenes meningitis in the Netherlands, 1985–2014: A nationwide surveillance study , 2017, The Journal of infection.
[48] E. D. Khilazheva,et al. Neuroinflammation and Infection: Molecular Mechanisms Associated with Dysfunction of Neurovascular Unit , 2017, Front. Cell. Infect. Microbiol..
[49] A. van der Ende,et al. pIgR and PECAM-1 bind to pneumococcal adhesins RrgA and PspC mediating bacterial brain invasion , 2017, The Journal of experimental medicine.
[50] P. Ravaud,et al. Clinical features and prognostic factors of listeriosis: the MONALISA national prospective cohort study. , 2017, The Lancet. Infectious diseases.
[51] M. Brouwer,et al. MONALISA: a grim picture of listeriosis. , 2017, The Lancet. Infectious diseases.
[52] S. Bentley,et al. Benzalkonium tolerance genes and outcome in Listeria monocytogenes meningitis , 2017, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[53] L. Vaz. Meningococcal Disease , 2017, Pediatrics in Review.
[54] A. Michelucci,et al. Cellular and Molecular Characterization of Microglia: A Unique Immune Cell Population , 2017, Front. Immunol..
[55] I. Galea,et al. The blood-brain barrier in systemic inflammation , 2017, Brain, Behavior, and Immunity.
[56] Manoj Kumar,et al. INGE GRUNDKE-IQBAL AWARD FOR ALZHEIMER’S RESEARCH: NEUROTOXIC REACTIVE ASTROCYTES ARE INDUCED BY ACTIVATED MICROGLIA , 2019, Alzheimer's & Dementia.
[57] R. Heyderman,et al. Prediction of Outcome From Adult Bacterial Meningitis in a High-HIV-Seroprevalence, Resource-Poor Setting Using the Malawi Adult Meningitis Score (MAMS) , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[58] H. Forssberg,et al. The bacterial peptidoglycan-sensing molecule Pglyrp2 modulates brain development and behavior , 2016, Molecular Psychiatry.
[59] C. Whitney,et al. Community-acquired bacterial meningitis , 2016, Nature Reviews Disease Primers.
[60] H. Pfister,et al. Dramatic reduction of mortality in pneumococcal meningitis , 2016, Critical Care.
[61] N. Wieselthaler,et al. Imaging Features of the Brain, Cerebral Vessels and Spine in Pediatric Tuberculous Meningitis With Associated Hydrocephalus , 2016, The Pediatric infectious disease journal.
[62] N. Govender,et al. The Epidemiology of Meningitis among Adults in a South African Province with a High HIV Prevalence, 2009-2012 , 2016, PloS one.
[63] S. Nadel. Treatment of Meningococcal Disease. , 2016, The Journal of adolescent health : official publication of the Society for Adolescent Medicine.
[64] Geneviève Garriss,et al. Pneumococcal meningitis is promoted by single cocci expressing pilus adhesin RrgA. , 2016, The Journal of clinical investigation.
[65] O. Cars,et al. UN High-Level Meeting on antimicrobials—what do we need? , 2016, The Lancet.
[66] M. Brouwer,et al. Neurological sequelae of bacterial meningitis. , 2016, The Journal of infection.
[67] J. Vazquez,et al. Global Meningococcal Initiative: guidelines for diagnosis and confirmation of invasive meningococcal disease , 2016, Epidemiology and Infection.
[68] K. Carroll,et al. Multicenter Evaluation of BioFire FilmArray Meningitis/Encephalitis Panel for Detection of Bacteria, Viruses, and Yeast in Cerebrospinal Fluid Specimens , 2016, Journal of Clinical Microbiology.
[69] J. V. van Dijl,et al. How Does Streptococcus pneumoniae Invade the Brain? , 2016, Trends in microbiology.
[70] N. Beeching,et al. The UK joint specialist societies guideline on the diagnosis and management of acute meningitis and meningococcal sepsis in immunocompetent adults. , 2016, The Journal of infection.
[71] Mamta B. Singh,et al. Corticosteroids for managing tuberculous meningitis , 2016, The Cochrane database of systematic reviews.
[72] B. Baban,et al. Blood–brain barrier breakdown promotes macrophage infiltration and cognitive impairment in leptin receptor-deficient mice , 2016, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[73] A. van der Ende,et al. Community-acquired bacterial meningitis in adults in the Netherlands, 2006-14: a prospective cohort study. , 2016, The Lancet. Infectious diseases.
[74] A. Figaji,et al. Clinical characteristics and neurodevelopmental outcomes of children with tuberculous meningitis and hydrocephalus , 2016, Developmental medicine and child neurology.
[75] K. Ishida,et al. Spontaneous Escherichia coli bacterial meningitis mimicking heatstroke in an adult , 2016, Clinical case reports.
[76] A. Lindstrand,et al. Effects of PCV7 and PCV13 on invasive pneumococcal disease and carriage in Stockholm, Sweden , 2016, European Respiratory Journal.
[77] Franziska Wulf,et al. Immunology A Short Course , 2016 .
[78] J. Quevedo,et al. Role of Microglial Activation in the Pathophysiology of Bacterial Meningitis , 2016, Molecular Neurobiology.
[79] M. Brouwer,et al. Corticosteroids for acute bacterial meningitis. , 2015, The Cochrane database of systematic reviews.
[80] S. Esposito,et al. Meningococcal disease in childhood: epidemiology, clinical features and prevention , 2015, Journal of preventive medicine and hygiene.
[81] Q. Dube,et al. Improving the outcome of bacterial meningitis in newborn infants in Africa: reflections on recent progress , 2015, Current opinion in infectious diseases.
[82] Christopher Gilpin,et al. WHO's new End TB Strategy , 2015, The Lancet.
[83] R. Rappuoli,et al. Neisseria meningitidis: pathogenesis and immunity. , 2015, Current opinion in microbiology.
[84] J. Frade,et al. Neuronal cell cycle: the neuron itself and its circumstances , 2015, Cell cycle.
[85] M. Kalin,et al. Clinical manifestations of invasive pneumococcal disease by vaccine and non-vaccine types , 2014, European Respiratory Journal.
[86] A. Benedetti,et al. Treatment outcomes of childhood tuberculous meningitis: a systematic review and meta-analysis. , 2014, The Lancet. Infectious diseases.
[87] Tami D. Lieberman,et al. Alternating antibiotic treatments constrain evolutionary paths to multidrug resistance , 2014, Proceedings of the National Academy of Sciences.
[88] D. Granoff,et al. Human Factor H (FH) Impairs Protective Meningococcal Anti-FHbp Antibody Responses and the Antibodies Enhance FH Binding , 2014, mBio.
[89] Jon C. Aster,et al. Robbins & Cotran Pathologic Basis of Disease , 2014 .
[90] J. Quevedo,et al. Environmental enrichment restores cognitive deficits induced by experimental childhood meningitis. , 2014, Revista brasileira de psiquiatria.
[91] A. van der Ende,et al. Cerebrospinal fluid inflammatory markers in patients with Listeria monocytogenes meningitis , 2014, BBA clinical.
[92] A. van der Ende,et al. Outcome in patients with bacterial meningitis presenting with a minimal Glasgow Coma Scale score , 2014, Neurology: Neuroimmunology & Neuroinflammation.
[93] Yu-Qiang Ding,et al. Minocycline and Risperidone Prevent Microglia Activation and Rescue Behavioral Deficits Induced by Neonatal Intrahippocampal Injection of Lipopolysaccharide in Rats , 2014, PloS one.
[94] M. Molyneux,et al. Bacterial Meningitis in Malawian Adults, Adolescents, and Children During the Era of Antiretroviral Scale-up and Haemophilus influenzae Type b Vaccination, 2000–2012 , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[95] T. van der Poll,et al. Host innate immune responses to sepsis , 2013, Virulence.
[96] S. Heckenberg,et al. Bacterial meningitis. , 2014, Handbook of clinical neurology.
[97] J. Luo,et al. Phagocytosis of Microglia in the Central Nervous System Diseases , 2014, Molecular Neurobiology.
[98] A. Teixeira,et al. Pathophysiology of neonatal acute bacterial meningitis. , 2013, Journal of medical microbiology.
[99] B. Stoll,et al. Neonatal severe bacterial infection impairment estimates in South Asia, sub-Saharan Africa, and Latin America for 2010 , 2013, Pediatric Research.
[100] Johan Schoeman,et al. Tuberculous meningitis: more questions, still too few answers , 2013, The Lancet Neurology.
[101] P. Coll,et al. Spontaneous gram-negative bacillary meningitis in adult patients: characteristics and outcome , 2013, BMC Infectious Diseases.
[102] Z. Bhutta,et al. Global epidemiology of invasive meningococcal disease , 2013, Population Health Metrics.
[103] O. Yeǧin,et al. Escherichia coli brain abscess in a twin pair associated with TLR4 gene mutation , 2013, Pediatrics international : official journal of the Japan Pediatric Society.
[104] S. Leib,et al. Cerebrospinal-fluid cytokine and chemokine profile in patients with pneumococcal and meningococcal meningitis , 2013, BMC Infectious Diseases.
[105] G. Molema,et al. University of Groningen Interactions between Blood-Borne Streptococcus pneumoniae and the Blood-Brain Barrier Preceding Meningitis , 2018 .
[106] A. van der Ende,et al. Listeria monocytogenes sequence type 6 and increased rate of unfavorable outcome in meningitis: epidemiologic cohort study. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[107] H. Kumar,et al. Recognition of bacterial infection by innate immune sensors , 2013, Critical reviews in microbiology.
[108] B. Wren,et al. Altered Innate Defenses in the Neonatal Gastrointestinal Tract in Response to Colonization by Neuropathogenic Escherichia coli , 2013, Infection and Immunity.
[109] H. Luma,et al. Tuberculous meningitis: presentation, diagnosis and outcome in hiv-infected patients at the douala general hospital, cameroon: a cross sectional study , 2013, AIDS Research and Therapy.
[110] G. Molema,et al. Signalling or binding: the role of the platelet‐activating factor receptor in invasive pneumococcal disease , 2013, Cellular microbiology.
[111] S. Salekeen,et al. Clinical course, complications and predictors of mortality in patients with tuberculous meningitis--an experience of fifty two cases at Civil Hospital Karachi, Pakistan. , 2013, JPMA. The Journal of the Pakistan Medical Association.
[112] A. Mildner,et al. Resistance of the Brain to Escherichia coli K1 Infection Depends on MyD88 Signaling and the Contribution of Neutrophils and Monocytes , 2013, Infection and Immunity.
[113] P. Coll,et al. The spectrum of acute bacterial meningitis in elderly patients , 2013, BMC Infectious Diseases.
[114] V. Perry,et al. Review: Activation patterns of microglia and their identification in the human brain , 2013, Neuropathology and applied neurobiology.
[115] E. Kashibu,et al. Bacterial isolates from cerebrospinal fluid of children with suspected acute meningitis in a Nigerian tertiary hospital. , 2013, The Nigerian postgraduate medical journal.
[116] A. Ramzan,et al. Childhood tubercular meningitis: an institutional experience and analysis of predictors of outcome. , 2013, Pediatric neurology.
[117] O. Baud,et al. Neonatal bacterial meningitis. , 2013, Handbook of clinical neurology.
[118] Tengda Xu,et al. Community acquired Listeria monocytogenes meningitis in adults , 2012 .
[119] R. Ransohoff,et al. Inflammatory cell trafficking across the blood–brain barrier: chemokine regulation and in vitro models , 2012, Immunological reviews.
[120] K. Kim. Current concepts on the pathogenesis of Escherichia coli meningitis: implications for therapy and prevention , 2012, Current opinion in infectious diseases.
[121] A. M. van Furth,et al. Seasonal variation in the incidence rate of tuberculous meningitis is associated with sunshine hours , 2012, Epidemiology and Infection.
[122] V. Vaillant,et al. Incidence of listeriosis and related mortality among groups at risk of acquiring listeriosis. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[123] N. Rouphael,et al. Neisseria meningitidis: biology, microbiology, and epidemiology. , 2012, Methods in molecular biology.
[124] S. Nomura,et al. Fulminant Tuberculous Meningitis , 2012 .
[125] Nicholas A. Be,et al. Role of Mycobacterium tuberculosis pknD in the Pathogenesis of central nervous system tuberculosis , 2012, BMC Microbiology.
[126] M. Lipsitch,et al. Serotype replacement in disease after pneumococcal vaccination , 2011, The Lancet.
[127] W. Pan,et al. Cytokine signaling modulates blood-brain barrier function. , 2011, Current pharmaceutical design.
[128] P. Berche,et al. Diagnosis of Listeria monocytogenes Meningoencephalitis by Real-Time PCR for the hly Gene , 2011, Journal of Clinical Microbiology.
[129] Diederik van de Beek,et al. Pathogenesis and Pathophysiology of Pneumococcal Meningitis , 2011, Clinical Microbiology Reviews.
[130] O. Swann,et al. Systematic review: neonatal meningitis in the developing world , 2011, Tropical medicine & international health : TM & IH.
[131] J. Laubscher,et al. The Role of Aspirin in Childhood Tuberculous Meningitis , 2011, Journal of child neurology.
[132] Aruna Chandran,et al. Long-term Sequelae of Childhood Bacterial Meningitis: An Underappreciated Problem , 2011, The Pediatric infectious disease journal.
[133] Guy Thwaites,et al. Tuberculous meningitis: a uniform case definition for use in clinical research. , 2010, The Lancet. Infectious diseases.
[134] A. Figaji,et al. The neurosurgical and acute care management of tuberculous meningitis: evidence and current practice. , 2010, Tuberculosis.
[135] B. Robertson,et al. The mechanisms and consequences of the extra-pulmonary dissemination of Mycobacterium tuberculosis. , 2010, Tuberculosis.
[136] G. Sengoz,et al. Predictors of mortality in tuberculous meningitis: a multivariate analysis of 160 cases. , 2010, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[137] F. Sörgel,et al. Penetration of Drugs through the Blood-Cerebrospinal Fluid/Blood-Brain Barrier for Treatment of Central Nervous System Infections , 2010, Clinical Microbiology Reviews.
[138] R. Nau,et al. Mechanisms of injury in bacterial meningitis , 2010, Current opinion in neurology.
[139] I. Rudan,et al. Global and regional risk of disabling sequelae from bacterial meningitis: a systematic review and meta-analysis. , 2010, The Lancet. Infectious diseases.
[140] Chien-Chang Yang,et al. Prognostic factors of tuberculous meningitis in adults: a 6-year retrospective study at a tertiary hospital in northern Taiwan. , 2010, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.
[141] A. Iwasaki,et al. Regulation of Adaptive Immunity by the Innate Immune System , 2010, Science.
[142] S. Leib,et al. Pathogenesis and pathophysiology of bacterial CNS infections. , 2010, Handbook of clinical neurology.
[143] K. Kim. Acute bacterial meningitis in infants and children. , 2010, The Lancet. Infectious diseases.
[144] J. Weber,et al. Review: Pathophysiology and treatment of bacterial meningitis , 2009, Therapeutic advances in neurological disorders.
[145] O. Levine,et al. Sequelae due to bacterial meningitis among African children: a systematic literature review , 2009, BMC medicine.
[146] T. Cherian,et al. Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates , 2009, The Lancet.
[147] P. Donald,et al. Tuberculous cerebrovascular disease: a review. , 2009, The Journal of infection.
[148] V. Nizet,et al. The surface-anchored NanA protein promotes pneumococcal brain endothelial cell invasion , 2009, The Journal of experimental medicine.
[149] E. Tuomanen,et al. Laminin receptor initiates bacterial contact with the blood brain barrier in experimental meningitis models. , 2009, The Journal of clinical investigation.
[150] S. Akira. Innate immunity to pathogens: diversity in receptors for microbial recognition , 2009, Immunological reviews.
[151] C. Terwee,et al. Twenty Years of Pediatric Tuberculous Meningitis: A Retrospective Cohort Study in the Western Cape of South Africa , 2009, Pediatrics.
[152] A. Mildner,et al. Toll-Like Receptor Prestimulation Increases Phagocytosis of Escherichia coli DH5α and Escherichia coli K1 Strains by Murine Microglial Cells , 2008, Infection and Immunity.
[153] H. Wagner,et al. Innate immunity to pneumococcal infection of the central nervous system depends on toll-like receptor (TLR) 2 and TLR4. , 2008, The Journal of infectious diseases.
[154] J. Luzio,et al. Differential expression of the polysialyl capsule during blood-to-brain transit of neuropathogenic Escherichia coli K1. , 2008, Microbiology.
[155] K. Kim. Mechanisms of microbial traversal of the blood–brain barrier , 2008, Nature Reviews Microbiology.
[156] P. Reiss,et al. Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settings. , 2008, The Lancet. Infectious diseases.
[157] M. J. Simões,et al. Molecular surveillance of Neisseria meningitidis capsular switching in Portugal, 2002–2006 , 2008, Epidemiology and Infection.
[158] A. Chan,et al. A generic mechanism in Neisseria meningitidis for enhanced resistance against bactericidal antibodies , 2008, The Journal of experimental medicine.
[159] T. Molitor,et al. Central Nervous System Tuberculosis: Pathogenesis and Clinical Aspects , 2008, Clinical Microbiology Reviews.
[160] J. Farrar,et al. The Influence of Host and Bacterial Genotype on the Development of Disseminated Disease with Mycobacterium tuberculosis , 2008, PLoS pathogens.
[161] C. Whitty,et al. Corticosteroids for bacterial meningitis in adults in sub-Saharan Africa. , 2007, The New England journal of medicine.
[162] R. Rappuoli,et al. RrgA is a pilus-associated adhesin in Streptococcus pneumoniae , 2007, Molecular microbiology.
[163] B. Greenwood,et al. Epidemic meningitis, meningococcaemia, and Neisseria meningitidis , 2007, The Lancet.
[164] G. Marks,et al. A polymorphism in the P2X7 gene increases susceptibility to extrapulmonary tuberculosis. , 2007, American journal of respiratory and critical care medicine.
[165] T. Mcintosh,et al. The duality of the inflammatory response to traumatic brain injury , 2001, Molecular Neurobiology.
[166] S. Heckenberg,et al. Community-acquired Listeria monocytogenes meningitis in adults. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[167] L. Zhao,et al. A polymorphism in Toll-interleukin 1 receptor domain containing adaptor protein is associated with susceptibility to meningeal tuberculosis. , 2006, The Journal of infectious diseases.
[168] Guy Thwaites,et al. Beijing Genotype of Mycobacterium tuberculosis Is Significantly Associated with Human Immunodeficiency Virus Infection and Multidrug Resistance in Cases of Tuberculous Meningitis , 2006, Journal of Clinical Microbiology.
[169] Etienne Carbonnelle,et al. A systematic genetic analysis in Neisseria meningitidis defines the Pil proteins required for assembly, functionality, stabilization and export of type IV pili , 2006, Molecular microbiology.
[170] W. Banks,et al. Release of cytokines by brain endothelial cells: A polarized response to lipopolysaccharide , 2006, Brain, Behavior, and Immunity.
[171] A. Charbit,et al. Listeriolysin O: a key protein of Listeria monocytogenes with multiple functions. , 2006, FEMS microbiology reviews.
[172] W. Bishai,et al. Mycobacterium tuberculosis invasion and traversal across an in vitro human blood-brain barrier as a pathogenic mechanism for central nervous system tuberculosis. , 2006, The Journal of infectious diseases.
[173] M. Mendelson,et al. Intractable Intracranial Tuberculous Infection Responsive to Thalidomide: Report of Four Cases , 2006, Journal of child neurology.
[174] L. Peterson. Penicillins for treatment of pneumococcal pneumonia: does in vitro resistance really matter? , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[175] Allan R Tunkel,et al. Community-acquired bacterial meningitis in adults. , 2006, The New England journal of medicine.
[176] D. Hamer,et al. Rapid Diagnosis of Pneumococcal Meningitis: Implications for Treatment and Measuring Disease Burden , 2005, The Pediatric infectious disease journal.
[177] A. Blom,et al. Binding of the Complement Inhibitor C4bp to Serogroup B Neisseria meningitidis 1 , 2005, The Journal of Immunology.
[178] Liem Nguyen,et al. The Trojan horse: survival tactics of pathogenic mycobacteria in macrophages. , 2005, Trends in cell biology.
[179] P. Donald,et al. Tuberculous meningitis and miliary tuberculosis: the Rich focus revisited. , 2005, The Journal of infection.
[180] B. Genton,et al. Cerebrospinal fluid lactate in 78 cases of adult meningitis , 2005, Intensive Care Medicine.
[181] P. Andrew,et al. The role of pneumolysin in pneumococcal pneumonia and meningitis , 2004, Clinical and experimental immunology.
[182] Martijn Weisfelt,et al. Clinical features and prognostic factors in adults with bacterial meningitis. , 2004, The New England journal of medicine.
[183] Raj Kumar,et al. Tuberculous brain stem abscesses in children , 2004, Journal of Pediatric Neurology.
[184] P. Haslett,et al. Adjunctive Thalidomide Therapy for Childhood Tuberculous Meningitis: Results of a Randomized Study , 2004, Journal of child neurology.
[185] D. Drevets,et al. Invasion of the Central Nervous System by Intracellular Bacteria , 2004, Clinical Microbiology Reviews.
[186] J. Kimpen,et al. Tuberculous meningitis and miliary tuberculosis in young children , 2004, Tropical medicine & international health : TM & IH.
[187] Harry L. T. Mobley,et al. Pathogenic Escherichia coli , 2004, Nature Reviews Microbiology.
[188] J. Chung,et al. Outer membrane protein A and cytotoxic necrotizing factor-1 use diverse signaling mechanisms for Escherichia coli K1 invasion of human brain microvascular endothelial cells. , 2003, Microbial pathogenesis.
[189] G. Overturf. Indications for the immunological evaluation of patients with meningitis. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[190] Clar Ni Chonghaile. Meningitis in Africa—tackling W135 , 2002, The Lancet.
[191] H. Pfister,et al. Pathogenesis and pathophysiology of pneumococcal meningitis. , 2002, The Lancet. Infectious diseases.
[192] P. Donald,et al. Long‐term follow up of childhood tuberculous meningitis , 2002 .
[193] F. Quinn,et al. Demonstration of spread by Mycobacterium tuberculosis bacilli in A549 epithelial cell monolayers. , 2002, FEMS microbiology letters.
[194] J. Chung,et al. Cytotoxic Necrotizing Factor-1 Contributes to Escherichia coli K1 Invasion of the Central Nervous System* , 2002, The Journal of Biological Chemistry.
[195] C.-H. Lu,et al. The Prognostic Factors of Adult Tuberculous Meningitis , 2001, Infection.
[196] P. Boquet. The cytotoxic necrotizing factor 1 (CNF1) from Escherichia coli. , 2001, Toxicon : official journal of the International Society on Toxinology.
[197] A. Fruth,et al. Enterohemorrhagic Escherichia coli. , 2001, Contributions to microbiology.
[198] P. Haslett,et al. Adjunctive Thalidomide Therapy of Childhood Tuberculous Meningitis: Possible Anti-Inflammatory Role , 2000, Journal of child neurology.
[199] V. Novelli,et al. Tuberculosis of the central nervous system in children: a 20-year survey. , 2000, The Journal of infection.
[200] Virji. The structural basis of CEACAM-receptor targeting by neisserial opa proteins: response , 2000, Trends in microbiology.
[201] D. Briles,et al. The pspC Gene of Streptococcus pneumoniae Encodes a Polymorphic Protein, PspC, Which Elicits Cross-Reactive Antibodies to PspA and Provides Immunity to Pneumococcal Bacteremia , 1999, Infection and Immunity.
[202] K. Haspolat,et al. Central Nervous System Tuberculosis in Children: A Review of 214 Cases , 1998, Pediatrics.
[203] E. Mylonakis,et al. Central Nervous System Infection with Listeria monocytogenes : 33 Years' Experience at a General Hospital and Review of 776 Episodes from the Literature , 1998, Medicine.
[204] E. Tuomanen,et al. PAf receptor anchors Streptococcus pneumoniae to activated human endothelial cells. , 1996, Advances in experimental medicine and biology.
[205] P. Donald,et al. Serial CT Scanning in Childhood Tuberculous Meningitis: Prognostic Features in 198 Cases , 1995, Journal of child neurology.
[206] P. Udani,et al. Pathology and pathogenetic mechanisms in neurotuberculosis. , 1995, Radiologic clinics of North America.
[207] V. Caviness,et al. Acute bacterial meningitis in adults. A review of 493 episodes. , 1993, The New England journal of medicine.
[208] P. Donald,et al. Cerebrospinal fluid investigations in tuberculous meningitis. , 1991, Annals of tropical paediatrics.
[209] R. Fallon,et al. LISTERIOSIS , 1985, The Lancet.
[210] M. Achtman,et al. Induction of bacteremia in newborn rats by Escherichia coli K1 is correlated with only certain O (lipopolysaccharide) antigen types , 1983, Infection and immunity.
[211] N. Niles. Pathologic Basis of Disease , 1974 .
[212] H. V. Smith. TUBERCULOUS MENINGITIS. , 1964, International journal of neurology.
[213] P. Daniel. Gross Morbid Anatomy of the Central Nervous System of Cases of Tuberculous Meningitis Treated with Streptomycin , 1949, Proceedings of the Royal Society of Medicine.
[214] W. Wood,et al. Acute meningitis. , 1947, The American journal of medicine.
[215] K. Shadan,et al. Available online: , 2012 .